Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

KTTA — Pasithea Therapeutics Corp. Dilution Risk Tracker

Track KTTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KTTA — Get alerts when the score changes →

As of October 13, 2026, Pasithea Therapeutics Corp. (KTTA) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Pasithea Therapeutics Corp. has a market capitalization of $14.95M, 33.41M shares outstanding, 21 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
37
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.75 below $1 exchange minimum
🔔 Track KTTA — Get forecast alerts →

Market Data

Market Cap$14.95M
Shares Outstanding33.41M
Float18.68M
Cash$45.66M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding33.41MVerified float table or market cache
Public Float18.68MVerified float table or market cache
Market Cap$14.95MMarket data cache
Cash Runway37.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: 3 1, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 32.4% shares (2026Q1 vs prior)
21 institutional holders · 17.07M shares
#1 Vivo Capital, LLC 4.20M shares
#2 JANUS HENDERSON GROUP PLC 4.20M shares
#3 Squadron Capital Management LLC 2.10M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest159.8K
Days to Cover1.1
% of Float0.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-30
8-K 8K EVENT 2026-05-04
3 FORM3 2026-04-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KTTA Dilution Snapshot

Pasithea Therapeutics Corp. (KTTA) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KTTA's DilutionScore is currently 41/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 37/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202641/100MEDIUM13 days
Aug 22 – Sep 30, 202637/100MEDIUM40 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202637/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KTTA shares outstanding have increased 44.7% from 23.09M (Apr 2026) to 33.41M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202633.41M18.68M▲ 36.64%
May 24, 202633.41M13.67M▲ 33.98%
Apr 27, 202624.94M10.20M▼ 17.88%
Apr 26, 202624.94M12.42M▼ 12.90%
Apr 11, 202624.94M14.26M▼ 14.87%
Apr 07, 202624.94M16.75M▲ 12.40%
Apr 01, 202623.09M14.90M▲ 210.21%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KTTA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KTTA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KTTA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KTTA
KTTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.